Molecular Tumour Board: Precision treatment for cancer of the thyroid

SPHERE Cancer CAG, in collaboration with Sydney Cancer Partners and the NSW Regional Cancer Research Network, is presenting the 2026 NSW Cancer Research Education Statewide Seminar Series. These online seminars are held on the 3rd Tuesday of each month.

The next seminar will be held on Tuesday,19th May at 12.30pm - 1.30pm via Microsoft Teams.

Session Information:
A Molecular Tumour Board (MTB) is a multi-disciplinary forum for discussion, interpretation and communication about molecular results that may have implications for patient care. The NSW Cancer Research Education Seminar Series features educational Molecular Tumour Board (MTB) sessions, including case-based presentations from MTBs working across both paediatric and adult cancers. 
 
This session will cover anatomy and histology of the thyroid, and pathology and molecular advances in thyroid cancer with a focus on improving diagnostic accuracy and opening the treatment pathway. 
 
The presentations will be followed by a Q&A.

Speakers:
Professor Ruta Gupta, Clinical Director, Tissue Pathology & Diagnostic Oncology, Royal Prince Alfred Hospital NSW Health Pathology & Sydney Medical School, The University of Sydney
Associate Professor Michael Elliot, Head & Neck Surgeon, Royal Prince Alfred Hospital & Chris O'Brien Lifehouse & Sydney Medical School, the University of Sydney
Dr Peter Luk, Staff Specialist, Tissue Pathology & Diagnostic Oncology, Royal Prince Alfred Hospital, NSW Health Pathology

Chair: Clinical Professor Rosemary Balleine, The Westmead Institute for Medical Research and University of Sydney

For more information and to register, click here